Submitted by Anonymous (not verified) on 13 September 2023 - 15:46
Human medicines European public assessment report (EPAR): Eylea, aflibercept, Wet Macular Degeneration;Macular Edema;Diabetes Complications, Date of authorisation: 21/11/2012, Revision: 30, Status: Authorised
Source: